Literature DB >> 24493701

The potential role of epigenetic modifications in the heritability of multiple sclerosis.

Yuan Zhou1, Steve Simpson, Adele F Holloway, Jac Charlesworth, Ingrid van der Mei, Bruce V Taylor.   

Abstract

It is now well established that both genetic and environmental factors contribute to and interact in the development of multiple sclerosis (MS). However, the currently described causal genetic variants do not explain the majority of the heritability of MS, resulting in 'missing heritability'. Epigenetic mechanisms, which principally include DNA methylation, histone modifications and microRNA-mediated post-transcriptional gene silencing, may contribute a significant component of this missing heritability. As the development of MS is a dynamic process potentially starting with inflammation, then demyelination, remyelination and neurodegeneration, we have reviewed the dynamic epigenetic changes in these aspects of MS pathogenesis and describe how environmental risk factors may interact with epigenetic changes to manifest in disease.

Entities:  

Keywords:  DNA methylation; Multiple sclerosis; epigenetics; histone modification; microRNA

Mesh:

Year:  2014        PMID: 24493701     DOI: 10.1177/1352458514520911

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

1.  Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis.

Authors:  Yuan Zhou; Ming Chen; Steve Simpson; Robyn M Lucas; Jac C Charlesworth; Nicholas Blackburn; Ingrid van der Mei; Anne-Louise Ponsonby; Bruce V Taylor
Journal:  Neurol Sci       Date:  2017-11-10       Impact factor: 3.307

2.  Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions.

Authors:  Melanie D Napier; Charles Poole; Glen A Satten; Allison Ashley-Koch; Ruth Ann Marrie; Dhelia M Williamson
Journal:  Arch Environ Occup Health       Date:  2014-08-19       Impact factor: 1.663

Review 3.  Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.

Authors:  Ian A MacDonald; Nathaniel A Hathaway
Journal:  Immunol Cell Biol       Date:  2014-12-23       Impact factor: 5.126

4.  A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients.

Authors:  M Pazhouhandeh; M-A Sahraian; S D Siadat; A Fateh; F Vaziri; F Tabrizi; F Ajorloo; A K Arshadi; E Fatemi; S Piri Gavgani; F Mahboudi; F Rahimi Jamnani
Journal:  Clin Exp Immunol       Date:  2018-01-25       Impact factor: 4.330

5.  Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up.

Authors:  Marja-Liisa Sumelahti; Markus H A Holmberg; Annukka Murtonen; Heini Huhtala; Irina Elovaara
Journal:  Mult Scler Int       Date:  2014-11-09

6.  Common functional polymorphism within miR-146a and miR-196a-2 as susceptibility loci for hepatocellular carcinoma: An updated meta-analysis.

Authors:  Ming Chen; Fukang Luo; Juanchun Yu; Guiming Xiang; Dongneng Jiang; Xiaoyun Pu
Journal:  Meta Gene       Date:  2015-11-15

7.  Heat Shock Protein 70 and The Risk of Multiple Sclerosis in The Iranian Population.

Authors:  Seyedeh Parisa Chavoshi Tarzjani; Seyed Abol Hassan Shahzadeh Fazeli; Mohammad Hossein Sanati; Seyed Massood Nabavi
Journal:  Cell J       Date:  2018-08-01       Impact factor: 2.479

8.  Taking a chance on epigenetics.

Authors:  Sophie A Lelièvre
Journal:  Front Genet       Date:  2014-07-04       Impact factor: 4.599

Review 9.  Epigenetic Drugs for Multiple Sclerosis.

Authors:  Jacob Peedicayil
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.

Authors:  Till F M Andlauer; Dorothea Buck; Gisela Antony; Antonios Bayas; Lukas Bechmann; Achim Berthele; Andrew Chan; Christiane Gasperi; Ralf Gold; Christiane Graetz; Jürgen Haas; Michael Hecker; Carmen Infante-Duarte; Matthias Knop; Tania Kümpfel; Volker Limmroth; Ralf A Linker; Verena Loleit; Felix Luessi; Sven G Meuth; Mark Mühlau; Sandra Nischwitz; Friedemann Paul; Michael Pütz; Tobias Ruck; Anke Salmen; Martin Stangel; Jan-Patrick Stellmann; Klarissa H Stürner; Björn Tackenberg; Florian Then Bergh; Hayrettin Tumani; Clemens Warnke; Frank Weber; Heinz Wiendl; Brigitte Wildemann; Uwe K Zettl; Ulf Ziemann; Frauke Zipp; Janine Arloth; Peter Weber; Milena Radivojkov-Blagojevic; Markus O Scheinhardt; Theresa Dankowski; Thomas Bettecken; Peter Lichtner; Darina Czamara; Tania Carrillo-Roa; Elisabeth B Binder; Klaus Berger; Lars Bertram; Andre Franke; Christian Gieger; Stefan Herms; Georg Homuth; Marcus Ising; Karl-Heinz Jöckel; Tim Kacprowski; Stefan Kloiber; Matthias Laudes; Wolfgang Lieb; Christina M Lill; Susanne Lucae; Thomas Meitinger; Susanne Moebus; Martina Müller-Nurasyid; Markus M Nöthen; Astrid Petersmann; Rajesh Rawal; Ulf Schminke; Konstantin Strauch; Henry Völzke; Melanie Waldenberger; Jürgen Wellmann; Eleonora Porcu; Antonella Mulas; Maristella Pitzalis; Carlo Sidore; Ilenia Zara; Francesco Cucca; Magdalena Zoledziewska; Andreas Ziegler; Bernhard Hemmer; Bertram Müller-Myhsok
Journal:  Sci Adv       Date:  2016-06-17       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.